Abstract:Cancer treatment is one of the major public health issues in the world. Tetrandrine (Tet) and fangchinoline (d-Tet) are two bis-benzyl isoquinoline alkaloids extracted from Stephania tetrandra S. Moore, and their antitumor activities have been confirmed. However, the effective dose of Tet and d-Tet were much higher than that of the positive control and failed to meet clinical standards. Therefore, in this study, as a continuation of our previous work to study and develop high-efficiency and low-toxic anti-tumor lead compounds, twenty new Tet and d-Tet derivatives were designed, synthesized and evaluated as antitumor agents against six cancer cell lines (H460, H520, HeLa, HepG-2, MCF-7, SW480 cell lines) and BEAS-2B normal cells by CCK-8 analysis. Ten derivatives showed better cytotoxic effects than the parent fangchinoline, of which 4g showed the strongest cell growth inhibitory activity with an IC50 value of 0.59 μM against A549 cells. Subsequently, the antitumor mechanism of 4g was studied by flow cytometry, Hoechst 33258, JC-1 staining, cell scratch, transwell migration, and Western blotting assays. These results showed that compound 4g could inhibit A549 cell proliferation by arresting the G2/M cell cycle and inhibiting cell migration and invasion by reducing MMP-2 and MMP-9 expression. Meanwhile, 4g could induce apoptosis of A549 cells through the intrinsic pathway regulated by mitochondria. In addition, compound 4g inhibited the phosphorylation of PI3K, Akt and mTOR, suggesting a correlation between blocking the PI3K/Akt/mTOR pathway and the above antitumor activities. These results suggest that compound 4g may be a future drug for the development of new potential drug candidates against lung cancer.

Design, Synthesis, and Biological Evaluation of N14-Amino Acid-Substituted Tetrandrine Derivatives as Potential Antitumor Agents against Human Colorectal Cancer

QSAR Research of Novel Tetrandrine Derivatives Against Human Hepatocellular Carcinoma.

Design, Synthesis of Novel Tetrandrine-14-l-Amino Acid and Tetrandrine-14-l-Amino Acid-Urea Derivatives As Potential Anti-Cancer Agents

Novel sulfonyl-substituted tetrandrine derivatives for colon cancer treatment by inducing mitochondrial apoptosis and inhibiting PI3K/AKT/mTOR pathway

Design and Synthesis of Novel C14-urea-tetrandrine Derivatives with Potent Anti-Cancer Activity.

Design, Synthesis and Bioactivity Investigation of Tetrandrine Derivatives As Potential Anti-Cancer Agents.

Design and Synthesis of Novel Tetrandrine Derivatives As Potential Anti-Tumor Agents Against Human Hepatocellular Carcinoma.

Tetrandrine Inhibits Wnt/β-Catenin Signaling and Suppresses Tumor Growth of Human Colorectal Cancer

Design and Synthesis of Tetrandrine Derivatives As Potential Anti‐tumor Agents Against A549 Cell Lines

Discovery of tetrandrine derivatives as tumor migration, invasion and angiogenesis inhibitors

Antitumor Agents 288: Design, Synthesis, SAR, and Biological Studies of Novel Heteroatom-Incorporated Antofine and Cryptopleurine Analogues As Potent and Selective Antitumor Agents.

Insights on Exploring the Therapeutic Potential and Structural Modification of Tetrandrine.

Design, synthesis and in vitro anticancer research of novel tetrandrine and fangchinoline derivatives

Design, synthesis and biological evaluation of tryptamine salicylic acid derivatives as potential antitumor agents.

Synthesis and Antitumor Evaluation of a Novel Series of Triaminotriazine Derivatives.

Tetrandrine, A Chinese Plant-Derived Alkaloid, Is A Potential Candidate For Cancer Chemotherapy

Advancement in Research on Anti-tumor Effect of Tetrandrine

Synthesis, Anticancer Activity, and Molecular Docking of New 1,2,3-Triazole Linked Tetrahydrocurcumin Derivatives

A Novel Class of C14-sulfonate-tetrandrine Derivatives As Potential Chemotherapeutic Agents for Hepatocellular Carcinoma

Design, Synthesis and Biological Evaluation of Novel 2,4,6-Trisubstituted Quinazoline Derivatives As Potential Antitumor Agents

Advanced Progress on the Effect and Mechanism of Tetrandrine